Patient receives first infusion of Biogen's controversial Alzheimer's drug
June 16, 2021 at 13:44 PM EDT
A 70-year-old man from Rhode Island on Wednesday was the first to receive an infusion outside of a clinical trial of Biogen's Alzheimer's drug, Aduhelm.
